Harmony Biosciences Holdings, Inc. (HRMY)
37.93
+0.85
(+2.29%)
USD |
NASDAQ |
Feb 10, 16:00
37.38
-0.55
(-1.45%)
After-Hours: 20:00
Harmony Biosciences Holdings EPS Diluted (Quarterly) : 0.8663 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Universal Health Services, Inc. | 5.858 |
| Liquidia Corp. | -0.0409 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 50.86M |
| Revenue (Quarterly) | 239.46M |
| Total Expenses (Quarterly) | 188.59M |
| Enterprise Value | 1.739B |
| Gross Profit Margin (Quarterly) | 72.60% |
| Profit Margin (Quarterly) | 21.24% |
| Earnings Yield | 8.37% |
| Operating Earnings Yield | 10.17% |
| Normalized Earnings Yield | 8.372 |